Navigation Links
Genetix Joins Molecular Devices: Combining Businesses to be in a Better Position to Serve Customers

SUNNYVALE, Calif., July 5, 2011 /PRNewswire/ -- Today, Molecular Devices, a leading provider of instruments, software, and consumables for drug discovery and life sciences research, announced that the Drug Discovery Division of Genetix will join Molecular Devices.


With the addition of Genetix, Molecular Devices continues to grow as a leading technology supply company for research, biotechnology, and pharmaceutical customers around the world.

Research in Pharma/Biotech is shifting toward biotherapeutic drugs (antibodies, proteins, and vaccines).  Two key products from Genetix, the ClonePix™ and QPix™ instrument platforms, address cell lines used in biotherapeutic research.  ClonePix is an automated mammalian cell selection platform that significantly expedites the process of identifying and selecting cells that produce biotherapeutic candidates, reducing both time and cost.

In addition, the CloneSelect™ Imager and CellReporter from Genetix will extend Molecular Devices' imaging portfolio. These products offer a good value for a budget conscious end user.

Commenting on the move, Mark Verheyden, President of Molecular Devices said, "We are excited about welcoming Genetix into the Molecular Devices team, knowing that the combined business will be better positioned to serve our customers."

About Molecular Devices, Inc.

At Molecular Devices we have one focus—our customers. Whether a long-time user, recent adopter, or prospective customer, your needs fuel our actions. We hire creative, best-in-class people to design, manufacture, and commercialize analytical instruments, software, and assays as well as provide dedicated follow-on support. Understanding your laboratory workflow is our top priority, and we direct product development toward solving your unique issues. Our instruments offer a full spectrum of detection technologies and meet all throughput needs—from dedicated, single-readout devices to multi-readout systems. Our goal is to deliver highly relevant analytical products to detect biology, decode data, and drive discovery. With headquarters in Silicon Valley and offices around the globe, we support and enrich efforts of the international BioResearch, BioPharma, and BioTesting communities. Visit us today at

Molecular Devices products are for Research Use Only. Not for use in diagnostic procedures.

Molecular Devices, the Molecular Devices logo, and all other trademarks are the property of Molecular Devices, Inc.

About Genetix

Founded in 1991, Genetix offers cell selection and cell imaging instrumentation and related products to basic and applied research scientists. The product range has been rebranded to carry the Molecular Devices name.

SOURCE Molecular Devices Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Imagenetix, Inc. Reports Third Quarter 2011 Results
2. Imagenetix, Inc. Provides Net Sales Guidance for the Second Quarter Fiscal 2011
3. Imagenetix Announces Issuance of New U.S. Patent for the Prevention and Treatment of Periodontal Disease
4. Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer
5. Bacterin Joins Russell 3000, Russell Microcap, and Russell Global Indexes
6. Drs. Ben Machielse Joins Omthera Pharmaceuticals, Inc. as Chief Operating Officer
7. Alan Dunton, M.D., Joins Board of Directors of Palatin Technologies, Inc.
8. Radient Pharmaceuticals Corporation Joins OTCQX
9. Dr. Assad Al-Ammar Joins Irvine Pharmaceutical Services as the New Minerals Analysis Manager in Response to the Growing Needs for USP Elemental Impurities Testing
10. Dr. F. John Mills Joins Intelsius Board of Directors as Non-Executive Chair
11. Mr. Charlie Alvarez Joins the Board of Sanomedics International Holdings, Inc.
Post Your Comments:
(Date:11/24/2015)... Nueva York , 24 de noviembre de ... del Avery Breathing Pacemaker System, se complace anunciar ... Ph.D. como consultor clínico. ... Foto -   ... Jonzon es un fisiólogo y consultor en neonatología ...
(Date:11/24/2015)... 2015 --> --> ... Market by Product Type (Bone Graft, Bine Graft Substitute, Platelet ... Posterior Lumbar Interbody Fusion), End User, and Geography - Global ... valued at $1.90 Billion in 2014 and is expected to ... during the forecast period of 2015 to 2020. ...
(Date:11/24/2015)... FRAMINGHAM, Mass. , Nov. 24, 2015   ... leading innovator of less-invasive, miniaturized circulatory support technologies that ... announced that President and Chief Executive Officer Doug ... Jaffray 27 th Annual Healthcare Conference on December ... being held December 1-2 in New York ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, officials ... the Narconon network, announced the release of a new cutting edge recovery program that ... has been working with drug- and alcohol-addicted individuals with the purpose to free addicts ...
(Date:11/25/2015)... , ... November 25, 2015 , ... Smiles by ... TMJ Disorder, Bruxism, and moderate facial wrinkling. While many patients are aware of the ... the great success Botox® delivers to those suffering with discomfort, soreness, and pain as ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted ... in Chicago, IL, UV Angel is evaluating the efficacy of its product and its ... units (totaling 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, ...
(Date:11/25/2015)... ... 25, 2015 , ... In honor of Pulmonary Hypertension Awareness ... groups responsible for advancing care for pulmonary hypertension (PH) patients and helping to ... will receive special recognition throughout 2016 as part of PHA’s 25th anniversary celebrations. ...
(Date:11/25/2015)... MA (PRWEB) , ... November 25, 2015 , ... Many ... — fatigue, fuzzy-headedness, weight gain, cold hands, and dry skin. But many people who ... their diet and exercise regimen instead of their thyroid, especially if they don’t have ...
Breaking Medicine News(10 mins):